CagA Protein of Helicobacter Pylori: a Hijacker of Gastric Epithelial Cell Signaling
Overview
Pharmacology
Authors
Affiliations
Epidemiological study has shown strong correlation between the Helicobacter pylori (H. pylori) infection and gastric carcinogenesis. However, the mechanism by which H. pylori induces gastric carcinogenesis is not known. In this review, we focused on the product of cytotoxin-associated gene A (CagA), one of the important virulence factors of H. pylori. H. pylori injects CagA protein into the host gastric epithelial cells through its needle-like structure, type IV secretion system. Injected CagA hijacks physiological signal transduction and causes pathological cellular response such as increased cell proliferation, motility, apoptosis and morphological change through different mechanisms. H. pylori has been shown to produce reactive oxygen species (ROS) in infected gastric mucosa. Although the main source of ROS production is possibly host neutrophil, we propose novel source of ROS production in this review; CagA itself can induce ROS production in gastric epithelial cell. Excessive ROS production in gastric epithelial cells can cause DNA damage and thus might involve in gastric carcinogenesis. Understanding the molecular mechanism by which H. pylori-induced carcinogenesis is important for developing new strategies against gastric cancer.
Gastric Cancer Vascularization and the Contribution of Reactive Oxygen Species.
Biagioni A, Peri S, Versienti G, Fiorillo C, Becatti M, Magnelli L Biomolecules. 2023; 13(6).
PMID: 37371466 PMC: 10296003. DOI: 10.3390/biom13060886.
Expression analysis of miRNA-155 level in related inflammation and chronic gastritis.
Mahboobi R, Fallah F, Yadegar A, Dara N, Kazemi Aghdam M, Asgari B Iran J Microbiol. 2023; 14(4):495-502.
PMID: 36721512 PMC: 9867648. DOI: 10.18502/ijm.v14i4.10235.
He S, Almalki A, Misbahuddin M Rafeeq , Sain Z, Alqosaibi A, Alnamshan M Molecules. 2022; 27(3).
PMID: 35164000 PMC: 8838247. DOI: 10.3390/molecules27030732.
The gut microbiota can be a potential regulator and treatment target of bone metastasis.
Contino K, Yadav H, Shiozawa Y Biochem Pharmacol. 2022; 197:114916.
PMID: 35041811 PMC: 8858876. DOI: 10.1016/j.bcp.2022.114916.
Lin T, Lan W, Chiu Y, Feng C, Chiu C, Kuo C Antioxidants (Basel). 2021; 10(8).
PMID: 34439541 PMC: 8389206. DOI: 10.3390/antiox10081293.